Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease

I Cortese, DS Reich, A Nath - Nature Reviews Neurology, 2021 - nature.com
Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused
by JC virus (JCV), a polyomavirus that commonly establishes persistent, asymptomatic …

Progressive multifocal leukoencephalopathy in HIV-1 infection

P Cinque, IJ Koralnik, S Gerevini, JM Miro… - The Lancet infectious …, 2009 - thelancet.com
Progressive multifocal leukoencephalopathy is caused by the JC polyomavirus (JCV) and is
one of the most feared complications of HIV-1 infection. Unlike other opportunistic infections …

Progressive multifocal leukoencephalopathy: current insights

M Kartau, JOT Sipilä, E Auvinen… - Degenerative …, 2019 - Taylor & Francis
Cases of PML should be evaluated according to predisposing factors, as these subgroups
differ by incidence rate, clinical course, and prognosis. The three most significant groups at …

Progressive multifocal leukoencephalopathy after natalizumab monotherapy

H Lindå, A von Heijne, EO Major… - … England Journal of …, 2009 - Mass Medical Soc
We describe progressive multifocal leukoencephalopathy (PML) caused by infection with
human polyomavirus JC virus in a patient with multiple sclerosis who was treated with …

JC virus infection of the brain

AK Bag, JK Curé, PR Chapman… - American Journal …, 2010 - Am Soc Neuroradiology
Since its initial description, there have been significant changes in the epidemiology,
pathogenesis, and clinical and imaging manifestations of JCV infection of brain. The most …

Determinants of survival in progressive multifocal leukoencephalopathy

A Marzocchetti, T Tompkins, DB Clifford, RT Gandhi… - Neurology, 2009 - AAN Enterprises
Background: We sought to characterize the role of immunologic, virologic, and radiologic
determinants of survival in patients with progressive multifocal leukoencephalopathy (PML) …

Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study

N Khanna, L Elzi, NJ Mueller, C Garzoni… - Clinical infectious …, 2009 - academic.oup.com
Background. We investigated the incidence and outcome of progressive multifocal
leukoencephalopathy (PML) in human immunodeficiency virus (HIV)–infected individuals …

Management of the immune reconstitution inflammatory syndrome

G Meintjes, J Scriven, S Marais - Current HIV/AIDS Reports, 2012 - Springer
The immune reconstitution inflammatory syndrome (IRIS) is a frequent early complication of
antiretroviral therapy (ART) in patients with advanced HIV. Because there is no confirmatory …

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

C Warnke, T Menge, HP Hartung, MK Racke… - Archives of …, 2010 - jamanetwork.com
Natalizumab (Tysabri) was the first monoclonal antibody approved for the treatment of
relapsing forms of multiple sclerosis (MS). After its initial approval, 3 patients undergoing …

Imaging manifestations of progressive multifocal leukoencephalopathy

R Shah, AK Bag, PR Chapman, JK Curé - Clinical radiology, 2010 - Elsevier
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease caused by
reactivation of JC virus in immunosuppressed patients. The diagnosis is usually suggested …